Long-run savings associated with surgical aortic valve replacement using a RESILIA tissue bioprosthetic valve versus a mechanical valve

References

• Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American college of cardiology/American heart association task force on clinical practice guidelines. J Am Coll Cardiol. 2017;70(2):252–289.
   PubMed Web of Science ®Google Scholar
• Nkomo VT, Gardin JM, Skelton TN, et al. Burden of valvular heart diseases: a population-based study. The Lancet. 2006;368(9540):1005–1011.
   PubMed Web of Science ®Google Scholar
• Etnel JR, Huygens SA, Grashuis P, et al. Bioprosthetic aortic valve replacement in nonelderly adults: a systematic review, meta-analysis, and microsimulation. Circ Cardiovasc Qual Outcomes. 2019;12(2):e005481.
   PubMed Web of Science ®Google Scholar
• Glaser N, Jackson V, Holzmann MJ, et al. Aortic valve replacement with mechanical vs. biological prostheses in patients aged 50–69 years. Eur Heart J. 2016;37(34):2658–2667.
   PubMed Web of Science ®Google Scholar
• Hirji SA, Kolkailah AA, Ramirez-Del Val F, et al. Mechanical versus bioprosthetic aortic valve replacement in patients aged 50 years and younger. Ann Thorac Surg. 2018;106(4):1113–1120.
   PubMed Web of Science ®Google Scholar
• Isaacs AJ, Shuhaiber J, Salemi A, et al. National trends in utilization and in-hospital outcomes of mechanical versus bioprosthetic aortic valve replacements. J Thorac Cardiovasc Surg. 2015;149(5):1262–1269.e3.
   PubMed Web of Science ®Google Scholar
• Kilic A, Bianco V, Gleason TG, et al. Hospital readmission rates are similar between patients with mechanical versus bioprosthetic aortic valves. J Card Surg. 2018;33(9):497–505.
   PubMed Web of Science ®Google Scholar
• Nguyen TC, Walker T, Gunnarsson C, et al. Long-term healthcare expenditures over time for tissue and mechanical aortic valve replacement. Ann Thorac Surg. 2021;112(2):526–531.
   PubMed Web of Science ®Google Scholar
• Son J, Cho YH, Jeong DS, et al. Mechanical versus tissue aortic prosthesis in sexagenarians: comparison of hemodynamic and clinical outcomes. Korean J Thorac Cardiovasc Surg. 2018;51(2):100–108.
   PubMedGoogle Scholar
• Tong X, George MG, Gillespie C, et al. Trends in hospitalizations and cost associated with stroke by age, United States 2003–2012. Int J Stroke. 2016;11(8):874–881.
   PubMed Web of Science ®Google Scholar
• Webb JG, Mack MJ, White JM, et al. Transcatheter aortic valve implantation within degenerated aortic surgical bioprostheses: PARTNER 2 valve-in-valve registry. J Am Coll Cardiol. 2017;69(18):2253–2262.
   PubMed Web of Science ®Google Scholar
• Zhao DF, Seco M, Wu JJ, et al. Mechanical versus bioprosthetic aortic valve replacement in middle-aged adults: a systematic review and meta-analysis. Ann Thorac Surg. 2016;102(1):315–327.
   PubMed Web of Science ®Google Scholar
• Badhwar V, Ofenloch JC, Rovin JD, et al. Noninferiority of closely monitored mechanical valves to bioprostheses overshadowed by early mortality benefit in younger patients. Ann Thorac Surg. 2012;93(3):748–753.
   PubMed Web of Science ®Google Scholar
• Bourguignon F, Rogers FH. Distributional effects of educational improvements: are we using the wrong model? Econom Educ Rev. 2007;26(6):735–746.
   Web of Science ®Google Scholar
• Bourguignon T, Bouquiaux-Stablo A-L, Candolfi P, et al. Very long-term outcomes of the Carpentier-Edwards perimount valve in aortic position. Ann Thorac Surg. 2015;99(3):831–837.
   PubMed Web of Science ®Google Scholar
• Dangas GD, Weitz JI, Giustino G, et al. Prosthetic heart valve thrombosis. J Am Coll Cardiol. 2016;68(24):2670–2689.
   PubMed Web of Science ®Google Scholar
• Flameng W, Hermans H, Verbeken E, et al. A randomized assessment of an advanced tissue preservation technology in the juvenile sheep model. J Thorac Cardiovasc Surg. 2015;149(1):340–345.
   PubMed Web of Science ®Google Scholar
• Sadri V, Trusty PM, Madukauwa-David ID, et al. Long-term durability of a new surgical aortic valve: a 1 billion cycle in vitro study. JTCVS Open. 2022;9:59–69.
   PubMedGoogle Scholar
• Tod TJ, Gohres RA, Torky M, et al. Influence of tissue technology on pannus formation on bioprosthetic heart valves. Cardiovasc Eng Tech. 2021;12(4):418–425.
   PubMed Web of Science ®Google Scholar
• Puskas JD, Bavaria JE, Svensson LG, et al. The Commence trial: 2-year outcomes with an aortic bioprosthesis with RESILIA tissue. Eur J Cardiothorac Surg. 2017;52(3):432–439.
   PubMed Web of Science ®Google Scholar
• Bavaria JE, Griffith B, Heimansohn DA, et al. Five-year outcomes of the COMMENCE trial investigating aortic valve replacement with RESILIA tissue. Ann Thoracic Surg. 2022;2022:58.
   Google Scholar
• Bartus K, Litwinowicz R, Bilewska A, et al. Final 5-year outcomes following aortic valve replacement with a RESILIA™ tissue bioprosthesis. Eur J Cardiothorac Surg. 2021;59(2):434–441.
   PubMed Web of Science ®Google Scholar
• Drummond M, Barbieri M, Cook J, et al. Transferability of economic evaluations across jurisdictions: ISPOR good research practices task force report. Value Health. 2009;12(4):409–418.
   PubMed Web of Science ®Google Scholar
• Husereau D, Drummond M, Petrou S, et al. Consolidated health economic evaluation reporting standards (CHEERS)—explanation and elaboration: a report of the ISPOR health economic evaluation publication guidelines good reporting practices task force. Value Health. 2013;16(2):231–250.
   PubMed Web of Science ®Google Scholar
• Neumann PJ, Sanders GD, Russell LB, et al. Cost-effectiveness in health and medicine. Oxford: Oxford University Press; 2016.
   Google Scholar
• Husereau D, Drummond M, Augustovski F, et al. Consolidated health economic evaluation reporting standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations. Int J Technol Assess Health Care. 2022;38(1):32.
   Web of Science ®Google Scholar
• Nguyen T, Walker T, Moore M, et al. Long-term healthcare expenditures over time for tissue and mechanical aortic valve replacement. Ann Thoracic Surg. 2021;112(2):526–531.
   PubMed Web of Science ®Google Scholar
• Akins CW, Miller DC, Turina MI, et al. Guidelines for reporting mortality and morbidity after cardiac valve interventions. Eur J Cardiothorac Surg. 2008;33(4):523–528.
   PubMed Web of Science ®Google Scholar
• Bourguignon T, El Khoury R, Candolfi P, et al. Very long-term outcomes of the Carpentier-Edwards perimount aortic valve in patients aged 60 or younger. Ann Thorac Surg. 2015;100(3):853–859.
   PubMed Web of Science ®Google Scholar
• Bourguignon T, Lhommet P, El Khoury R, et al. Very long-term outcomes of the Carpentier-Edwards perimount aortic valve in patients aged 50–65 years. Eur J Cardiothorac Surg. 2016;49(5):1462–1468.
   PubMed Web of Science ®Google Scholar
• Dunn A, Grosse SD, Zuvekas SH. Adjusting health expenditures for inflation: a review of measures for health services research in the United States. Health Serv Res. 2018;53(1):175–196.
   PubMed Web of Science ®Google Scholar
• Grosse SD, Nelson RE, Nyarko KA, et al. The economic burden of incident venous thromboembolism in the United States: a review of estimated attributable healthcare costs. Thromb Res. 2016;137:3–10.
   PubMed Web of Science ®Google Scholar
• Morita Y, Haruna T, Haruna Y, et al. Thirty‐day readmission after infective endocarditis: analysis from a nationwide readmission database. J Am Heart Assoc. 2019;8(9):e011598.
   PubMed Web of Science ®Google Scholar
• Simon Ak A, Brown P, Reynolds M, et al. 90-Day cost and clinical outcomes comparing TAVR to SAVR: do the economics work? Presented at: American college of cardiology. Orlando, FL. Session Aortic Valve Disease: optimizing TAVR; 2018.
   Google Scholar
• Cooper Z, Craig SV, Gaynor M, et al. The price ain’t right? Hospital prices and health spending on the privately insured. Q J Econ. 2019;134(1):51–107.
   PubMed Web of Science ®Google Scholar
• Wang G, Zhang Z, Ayala C, et al. Costs of hospitalization for stroke patients aged 18–64 years in the United States. J Stroke Cerebrovasc Dis. 2014;23(5):861–868.
   PubMed Web of Science ®Google Scholar
• Bobade RA, Helmers RA, Jaeger TM, et al. Time-driven activity-based cost analysis for outpatient anticoagulation therapy: direct costs in a primary care setting with optimal performance. J Med Econ. 2019;22(5):471–477.
   PubMed Web of Science ®Google Scholar